No Data
No Data
Maxim Group Maintains Rezolute(RZLT.US) With Buy Rating
Rezolute Price Target Raised to $10.00/Share From $8.00 by Maxim Group
Rezolute Is Maintained at Buy by Maxim Group
Craig-Hallum Maintains Rezolute(RZLT.US) With Buy Rating, Announces Target Price $13
Analysts Offer Insights on Healthcare Companies: CVRx (CVRX), Adaptive Biotechnologies (ADPT) and Rezolute (RZLT)
Express News | HC Wainwright & Co. Reiterates Buy on Rezolute, Maintains $14 Price Target
No Data